Company / SG&A per Share
Co-Diagnostics, Inc. SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$8.22
FY2025
5-year range
$0.29 / $8.22
FY2021-FY2025
Trend
+1490.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +1491% YoY in FY2025, a notable deviation from the 8-year average annual change of +224%.
Based on SEC 10-K filings.
8.22 in FY2025 with a 5-year CAGR of +109.9%.
Increased from $0.46 to $8.22 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +188.7%
- 5-Year CAGR
- +109.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 1490.6% year-over-year.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.22 | +1490.6% |
| FY2024 | $0.52 | +11.7% |
| FY2023 | $0.46 | +35.4% |
| FY2022 | $0.34 | +17.8% |
| FY2021 | $0.29 | +43.8% |
| FY2020 | $0.20 | -27.0% |
| FY2019 | $0.28 | +9.9% |
| FY2018 | $0.25 | +211.7% |
| FY2017 | $0.08 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026